about
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patientsLipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats.The role of hippocampus in the pathophysiology of bipolar disorder.Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.Use and misuse of benzodiazepines in Brazil: a review.Sodium butyrate reverses the inhibition of Krebs cycle enzymes induced by amphetamine in the rat brain.Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.Modafinil effects on behavior and oxidative damage parameters in brain of wistar rats.Effects of maintenance electroshock on the oxidative damage parameters in the rat brain.Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis.Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats.Peripheral nucleotide hydrolysis in rats submitted to a model of electroconvulsive therapy.Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus.Dexamethasone treatment reverses cognitive impairment but increases brain oxidative stress in rats submitted to pneumococcal meningitis.LC/QTOF profile and preliminary stability studies of an enriched flavonoid fraction of Cecropia pachystachya Trécul leaves with potential antidepressant-like activity.Role of oxidative stress in the pathophysiology of pneumococcal meningitis.Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury.Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats.The gastrin-releasing peptide receptor as a therapeutic target in central nervous system disorders.The septic brain.Cognitive impairment in the septic brain.A phosphodiesterase 4-controlled switch between memory extinction and strengthening in the hippocampus.Role of oxidative stress in the pathophysiology of bipolar disorder.Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics.Animal models as tools to study the pathophysiology of depression.Contributions of animal models to the study of mood disorders.Sepsis in the central nervous system and antioxidant strategies with N-acetylcysteine, vitamins and statins.Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: insights in depression.Targets for adjunctive therapy in pneumococcal meningitis.Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders.Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain.The role of DNA methylation in the pathophysiology and treatment of bipolar disorder.Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL/6 mice infected with Plasmodium berghei (strain ANKA).A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress.Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants.Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder.
P50
Q24611774-DE8FF526-06AB-4658-8DD3-99DE6BF7C8C5Q31440143-6C17358D-7E09-4C22-84AC-EBACBD905090Q33296145-FE3FC7EC-4104-4207-A5EE-66ADDEF0BB8DQ33619092-500FE21F-9212-43F5-B60A-7265160868F6Q34336478-FD4330ED-8704-4ED8-9BCF-8EAAA0664D5DQ34357384-E12CEFC6-0A35-436E-B869-9D3079B83103Q34446887-9CBC5A01-5D44-4D15-99D6-18A753537D79Q34546206-CD67D297-CAED-4F5F-A9D8-DC8D6E4F690CQ34608384-F26A17CE-08A6-484B-B130-B5A7CDCF124CQ34645552-BE560756-3E95-4FF9-ADEA-2744191BD818Q34660667-4636748C-2C92-4575-BD78-C827031393C0Q34822609-172F0C4F-BE7C-4E6C-8E51-8C36CE6D74EBQ35157958-7AE951DB-CBC2-4BA2-8C59-DA508FA8E220Q35609310-65342A2E-C246-4F1E-BF02-64735D9019AAQ36332470-65BCF969-9DFB-4251-89AB-DA95291D6C97Q36879959-F141F451-1BBE-4A98-B280-E9799A62EB1BQ36902843-35E4E5AD-32F8-454B-B4B9-9B5A78673A79Q36993209-9B4E6327-AE8E-4CCD-AA1C-83EB6EBA50F2Q37067458-AC2C30AE-E1C0-4A5F-A287-AAA6D103CF3DQ37156575-FBA06124-8698-4493-A3AB-11BD39E563EFQ37522668-AEB66FAE-5763-4F30-AB4D-2F95C4A6E27AQ37640452-2B41CFD0-3D8E-4830-902A-592D7B9AA544Q37760462-9ADAB627-A514-46C4-8E22-27218010DD35Q38154174-1D3F9C07-2B4D-4480-9072-2BABCEDCCD63Q38165754-B86F92C1-B66E-4AEF-B79A-5514525F6BBCQ38165755-FC6B5E9E-9D37-4B66-9E7B-D578D952E4D5Q38170464-38AE4219-41EF-4F21-BF5F-18C0FD0E4D9CQ38223865-14D8ADBD-4E94-4A25-B611-A308BD2EE242Q38282002-4650BC58-5467-4731-B2A8-384BAAC94558Q38443269-F27428C3-B908-4FB6-BD9A-CF882A501EBCQ38485016-449F32B3-7BFD-4F9D-8E38-62A2B68D3490Q38586255-F0703CFE-6079-4A23-9240-96E70E6FA275Q38872287-BCE298B5-C383-4CAE-ADF3-E9F4190FE107Q38885804-6086A2A6-28D0-445B-B895-7433ED4FEEB5Q38932912-FF29668D-F947-44CF-A5F1-A7D75CB382E3Q38966365-4D10A106-2BBE-46E3-A674-9871543B8FEBQ39273936-B53338F2-058C-4250-9723-BA6FBBCFC094Q39312488-94920D90-9267-47B4-A785-5CA1FD6C92DFQ39940499-DB3596CE-FE0B-4B16-A36A-D2F3F8BABB93Q40234545-20BB57DE-AB5B-4E09-A3C8-AE84AB6AD8A4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
João Quevedo
@ast
João Quevedo
@en
João Quevedo
@es
João Quevedo
@nl
João Quevedo
@sl
type
label
João Quevedo
@ast
João Quevedo
@en
João Quevedo
@es
João Quevedo
@nl
João Quevedo
@sl
prefLabel
João Quevedo
@ast
João Quevedo
@en
João Quevedo
@es
João Quevedo
@nl
João Quevedo
@sl
P1053
E-5491-2013
P106
P1153
56971689500
P21
P31
P3829
P3835
joao-luciano-de-quevedo2
P496
0000-0003-3114-6611